Brokers Issue Forecasts for Astera Labs Q2 Earnings

Astera Labs, Inc. (NASDAQ:ALAB) – Equities research analysts at Northland Securities issued their Q2 2027 earnings per share estimates for shares of Astera Labs in a report issued on Wednesday, February 11th. Northland Securities analyst G. Richard forecasts that the company will post earnings of $0.51 per share for the quarter. Northland Securities currently has a “Outperform” rating and a $195.00 price target on the stock. The consensus estimate for Astera Labs’ current full-year earnings is $0.34 per share. Northland Securities also issued estimates for Astera Labs’ Q3 2027 earnings at $0.55 EPS and Q4 2027 earnings at $0.67 EPS.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, beating the consensus estimate of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.87%. The company had revenue of $270.58 million during the quarter, compared to analysts’ expectations of $249.46 million. During the same quarter in the prior year, the company earned $0.37 earnings per share. The business’s quarterly revenue was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS.

A number of other equities analysts also recently weighed in on the company. Raymond James Financial began coverage on Astera Labs in a research report on Friday, November 21st. They set a “hold” rating for the company. Royal Bank Of Canada began coverage on shares of Astera Labs in a research report on Wednesday, January 14th. They issued an “outperform” rating and a $225.00 price objective on the stock. BNP Paribas Exane started coverage on shares of Astera Labs in a report on Thursday, November 20th. They set an “outperform” rating for the company. Barclays set a $165.00 price target on shares of Astera Labs in a research note on Thursday, January 15th. Finally, Needham & Company LLC boosted their price target on shares of Astera Labs from $205.00 to $220.00 and gave the stock a “buy” rating in a research report on Wednesday, November 5th. Fourteen equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $192.89.

Astera Labs Trading Down 11.9%

ALAB opened at $126.58 on Friday. The stock has a market capitalization of $21.38 billion, a P/E ratio of 103.75, a P/E/G ratio of 1.96 and a beta of 1.50. The firm’s fifty day simple moving average is $164.73 and its 200 day simple moving average is $174.08. Astera Labs has a 12 month low of $47.13 and a 12 month high of $262.90.

Institutional Investors Weigh In On Astera Labs

A number of hedge funds and other institutional investors have recently modified their holdings of ALAB. United Capital Management of KS Inc. raised its position in shares of Astera Labs by 2.0% in the fourth quarter. United Capital Management of KS Inc. now owns 41,078 shares of the company’s stock valued at $6,834,000 after buying an additional 811 shares in the last quarter. Advisors Asset Management Inc. boosted its stake in shares of Astera Labs by 45.6% in the 4th quarter. Advisors Asset Management Inc. now owns 1,053 shares of the company’s stock valued at $175,000 after purchasing an additional 330 shares in the last quarter. Advocate Investing Services LLC acquired a new stake in Astera Labs in the fourth quarter valued at approximately $150,000. Orion Porfolio Solutions LLC grew its position in Astera Labs by 22.6% during the 4th quarter. Orion Porfolio Solutions LLC now owns 4,372 shares of the company’s stock worth $727,000 after acquiring an additional 805 shares during the last quarter. Finally, Cibc World Markets Corp bought a new stake in shares of Astera Labs during the fourth quarter worth about $21,417,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Insider Activity at Astera Labs

In other news, COO Sanjay Gajendra sold 90,459 shares of the company’s stock in a transaction dated Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $13,088,512.71. Following the sale, the chief operating officer directly owned 1,599,750 shares of the company’s stock, valued at approximately $231,467,827.50. This represents a 5.35% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, General Counsel Philip Mazzara sold 4,620 shares of the business’s stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $668,467.80. Following the transaction, the general counsel directly owned 147,040 shares in the company, valued at $21,275,217.60. The trade was a 3.05% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 576,936 shares of company stock worth $87,409,540 over the last ninety days. Company insiders own 12.50% of the company’s stock.

More Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q4 beat on revenue and EPS with strong growth and margins — the company reported $270.6M revenue, 75.7% gross margin and an EPS beat, and management issued solid Q1 guidance that underscores hyperscaler demand. ALAB Q4 Earnings Beat (Zacks)
• Positive Sentiment: Wall‑street analysts still see upside tied to large AI infrastructure customers (NVIDIA, AMD, Amazon, Google) and JPMorgan highlighted Astera as a beneficiary of AI buildout. That underpins medium‑term demand expectations. JPMorgan Upside Note (Benzinga)
• Neutral Sentiment: Analysts/transcripts available — full earnings call transcript and Seeking Alpha pieces provide granular color on product ramps (Scorpio X) and margin trajectory; read if you need detail on guidance cadence into H2/2027. Earnings Analysis & Transcript (Seeking Alpha)
• Neutral Sentiment: Reported short‑interest entries appear to be data anomalies (values show 0 and NaN); no actionable evidence of a meaningful short squeeze or buildup from the published figures. Earnings Call Transcript (MSN)
• Negative Sentiment: Investors are booking profits after a massive run-up; several outlets flagged profit‑taking and a “rich” valuation as reasons for the selloff despite the beat. Profit‑Taking After Earnings (Seeking Alpha)
• Negative Sentiment: Concerns about concentration and deal terms: coverage highlighted Amazon’s reported $6.5B engagement as a “double‑edged sword” (big revenue opportunity but customer concentration/contract risk), which weighed on sentiment. Amazon Deal Concerns (MarketWatch)
• Negative Sentiment: CFO change and other corporate developments introduced near‑term uncertainty; several writeups linked management changes to the intra‑day weakness as investors reassessed execution risk. Slide After Earnings, CFO Change (Benzinga)

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.